CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Synovis Life Technologies, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Synovis Life Technologies, Inc.
2575 University Avenue
Phone: (651) 796-7300p:651 796-7300 St. Paul, MN  55114  United States Ticker: SYNOSYNO

This company was Merged or Acquired on 2/14/2012.
This company ceased filing statements with the SEC on 2/24/2012.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Synovis Life Technologies, Inc. (Synovis) is a medical device company. The Company develops, manufactures and markets biological and mechanical products used by several surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. Its products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools. The Company operates in three segments: the surgical business, the microsurgical business, and the Ortho & Wound business. Its surgical business develops, manufactures, markets, and sells implantable biomaterial products and surgical tools. Its surgical business products include Peri-Strips, Tissue Guard, Veritas, and Surgical Tools. The Company’s microsurgical business develops, manufactures, markets, and sells devices serving the niche market of microsurgery. In February 2012, Baxter International Inc. acquired Synovis.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
-Yes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
10/31/201110/31/2011YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board John D.Seaberg 60 11/1/2010 1/2/2008
President, Chief Executive Officer, Director Richard W.Kramp 66 1/3/2007 8/30/2004
Chief Financial Officer, Vice President - Finance, Corporate Secretary Brett A.Reynolds 43 4/12/2005 4/12/2005
10 additional Officers and Directors records available in full report.

Business Names
Business Name
Bio-Vascular B.V., Breda
SYNO
Synovis Caribe, Inc.
Synovis Interventional Solutions, Inc.
Synovis Micro Companies Alliance, Inc.
Synovis Orthopedic & Woundcare, Inc.

General Information
Number of Employees: 330 (As of 12/1/2011)
Outstanding Shares: 11,167,690 (As of 12/1/2011)
Shareholders: 5,700
Stock Exchange: NASD
Federal Tax Id: 411526554
Fax Number: (651) 642-9018


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, September 18, 2019